Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cells
- PMID: 25973062
- PMCID: PMC4396316
Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cells
Abstract
Objective: To investigate whether celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, can attenuate proliferation, migration, invasion and MMP-14 expression in pancreatic cancer cells PANC-1 and the possible anti-tumor mechanism of celecoxib.
Methods: Human pancreatic cancer cell line PANC-1 cells were treated with diverse concentrations of celecoxib (20, 60, 100 μmol/L). Cell proliferation, invasion and migration capabilities were measured by MTT colorimetry, transwell invasion assay, and scratch assay separately. At the same time, the protein expression of COX-2 and MMP-14 was assessed by ELISA.
Results: The capabilities of proliferation, invasion and migration in PANC-1 cells were attenuated in a concentration-dependent manner after treated with celecoxib, followed by the down-regulation of the protein expression of COX-2 and MMP-14. In addition, MMP-14 expression was significantly positively correlated with COX-2 expression.
Conclusions: COX-2 inhibitor celecoxib can inhibit the proliferation, invasion and migration of PANC-1 cells via down-regulating the expression of MMP-14 in a concentration-dependent manner, thus contributing to its anti-tumor effect in pancreatic cancer.
Keywords: Pancreatic cancer; celecoxib; cyclooxygenase-2; matrix metalloproteinase-14.
Figures




Similar articles
-
Celecoxib suppresses fibroblast growth factor-2 expression in pancreatic ductal adenocarcinoma PANC-1 cells.Oncol Rep. 2016 Sep;36(3):1345-52. doi: 10.3892/or.2016.4924. Epub 2016 Jul 8. Oncol Rep. 2016. PMID: 27430377
-
Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3 / NF-kB and L1CAM activities.Pancreatology. 2018 Apr;18(3):328-333. doi: 10.1016/j.pan.2018.02.006. Epub 2018 Feb 15. Pancreatology. 2018. PMID: 29525378
-
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.Pharmazie. 2014 Feb;69(2):132-7. Pharmazie. 2014. PMID: 24640603
-
MMP-7 marks severe pancreatic cancer and alters tumor cell signaling by proteolytic release of ectodomains.Biochem Soc Trans. 2022 Apr 29;50(2):839-851. doi: 10.1042/BST20210640. Biochem Soc Trans. 2022. PMID: 35343563 Free PMC article. Review.
-
Celecoxib in Cancer Therapy and Prevention - Review.Curr Drug Targets. 2019;20(3):302-315. doi: 10.2174/1389450119666180803121737. Curr Drug Targets. 2019. PMID: 30073924 Review.
Cited by
-
Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?Front Oncol. 2021 Jul 20;11:594917. doi: 10.3389/fonc.2021.594917. eCollection 2021. Front Oncol. 2021. PMID: 34354940 Free PMC article. Review.
-
The Effects of Analgesics on the Migration of Pancreatic Cancer Cells.In Vivo. 2022 Mar-Apr;36(2):576-581. doi: 10.21873/invivo.12740. In Vivo. 2022. PMID: 35241509 Free PMC article.
-
Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer.Oncol Lett. 2016 Nov;12(5):3836-3844. doi: 10.3892/ol.2016.5207. Epub 2016 Sep 29. Oncol Lett. 2016. PMID: 27895738 Free PMC article.
-
Nimesulide inhibits proliferation and induces apoptosis of pancreatic cancer cells by enhancing expression of PTEN.Exp Ther Med. 2018 Jul;16(1):370-376. doi: 10.3892/etm.2018.6191. Epub 2018 May 18. Exp Ther Med. 2018. PMID: 29896263 Free PMC article.
-
Effects of metamizole, MAA, and paracetamol on proliferation, apoptosis, and necrosis in the pancreatic cancer cell lines PaTu 8988 t and Panc-1.BMC Pharmacol Toxicol. 2017 Dec 6;18(1):77. doi: 10.1186/s40360-017-0185-y. BMC Pharmacol Toxicol. 2017. PMID: 29208039 Free PMC article.
References
-
- Mihaljevic AL, Michalski CW, Friess H, Kleeff J. Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis. Langenbecks Arch Surg. 2010;395:295–308. - PubMed
-
- Haage A, Schneider IC. Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells. FASEB J. 2014;28:1–11. - PubMed
-
- Haage A, Nam DH, Ge X, Schneider IC. Matrix metalloproteinase-14 is a mechanically regulated activator of secreted MMPs and invasion. Biochem Biophys Res Commun. 2014;450:213–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials